79
But an argument broke out pretty quickly. In 2016, Maschmeyer then sold 710,000 Syntellix shares to Claassen. But the two continued to argue. For example, whether Claassen Maschmeyer still owes money.
The underlying facts arise from a partial judgment made by the Hanover Regional Court a few days ago:
Accordingly, Maschmeyer and Claassen had agreed that Maschmeyer would not only receive the agreed 7.30 euros per share but also a supplement if Claassen resold Maschmeyer’s Syntellix shares at a profit.